
Daniel R. Carcanague
Examiner (ID: 5382, Phone: (571)270-3023 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1621, 1625 |
| Total Applications | 1087 |
| Issued Applications | 878 |
| Pending Applications | 22 |
| Abandoned Applications | 208 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17800126
[patent_doc_number] => 11414406
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-16
[patent_title] => Antagonists of the muscarinic acetylcholine receptor M
[patent_app_type] => utility
[patent_app_number] => 16/966306
[patent_app_country] => US
[patent_app_date] => 2019-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21368
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 189
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16966306
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/966306 | Antagonists of the muscarinic acetylcholine receptor M | Jan 31, 2019 | Issued |
Array
(
[id] => 16628647
[patent_doc_number] => 20210047300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => HETERO RING-FUSED PHENYL COMPOUNDS FOR INHIBITING TNIK AND MEDICAL USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/967825
[patent_app_country] => US
[patent_app_date] => 2019-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10031
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16967825
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/967825 | Hetero ring-fused phenyl compounds for inhibiting TNIK and medical uses thereof | Jan 30, 2019 | Issued |
Array
(
[id] => 15363481
[patent_doc_number] => 20200017505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-16
[patent_title] => NITROGEN-CONTAINING HETEROCYCLIC AMIDE COMPOUND AND PHARMACEUTICAL USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/261792
[patent_app_country] => US
[patent_app_date] => 2019-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33832
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16261792
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/261792 | Nitrogen-containing heterocyclic amide compound and pharmaceutical use thereof | Jan 29, 2019 | Issued |
Array
(
[id] => 17407128
[patent_doc_number] => 11247997
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-15
[patent_title] => Compound and preparation and application thereof
[patent_app_type] => utility
[patent_app_number] => 16/480674
[patent_app_country] => US
[patent_app_date] => 2019-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 30
[patent_no_of_words] => 26389
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16480674
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/480674 | Compound and preparation and application thereof | Jan 27, 2019 | Issued |
Array
(
[id] => 14715437
[patent_doc_number] => 20190248782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-15
[patent_title] => METHOD FOR PREPARING MARAVIROC
[patent_app_type] => utility
[patent_app_number] => 16/257987
[patent_app_country] => US
[patent_app_date] => 2019-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2179
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16257987
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/257987 | Method for preparing Maraviroc | Jan 24, 2019 | Issued |
Array
(
[id] => 18102384
[patent_doc_number] => 11542259
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-03
[patent_title] => Compounds for the treatment of kinase-dependent disorders
[patent_app_type] => utility
[patent_app_number] => 16/964330
[patent_app_country] => US
[patent_app_date] => 2019-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69939
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16964330
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/964330 | Compounds for the treatment of kinase-dependent disorders | Jan 24, 2019 | Issued |
Array
(
[id] => 17996665
[patent_doc_number] => 11497751
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-15
[patent_title] => Modulators of Rho-associated protein kinase
[patent_app_type] => utility
[patent_app_number] => 16/964904
[patent_app_country] => US
[patent_app_date] => 2019-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 80057
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 518
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16964904
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/964904 | Modulators of Rho-associated protein kinase | Jan 24, 2019 | Issued |
Array
(
[id] => 16657344
[patent_doc_number] => 20210053980
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => Use of Pyridoxal Acetal Salts as Water-Triggered Profragrances
[patent_app_type] => utility
[patent_app_number] => 16/964804
[patent_app_country] => US
[patent_app_date] => 2019-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3460
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16964804
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/964804 | Use of pyridoxal acetal salts as water-triggered pro-fragrances | Jan 23, 2019 | Issued |
Array
(
[id] => 16613558
[patent_doc_number] => 20210032211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => PROCESSES FOR THE SYNTHESIS OF SULFENTRAZONE
[patent_app_type] => utility
[patent_app_number] => 16/962834
[patent_app_country] => US
[patent_app_date] => 2019-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3962
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16962834
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/962834 | PROCESSES FOR THE SYNTHESIS OF SULFENTRAZONE | Jan 17, 2019 | Abandoned |
Array
(
[id] => 15726705
[patent_doc_number] => 10611773
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-07
[patent_title] => Macrocyclization reactions and intermediates and other fragments useful in the synthesis of analogs of halichondrin B
[patent_app_type] => utility
[patent_app_number] => 16/246999
[patent_app_country] => US
[patent_app_date] => 2019-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 54551
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16246999
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/246999 | Macrocyclization reactions and intermediates and other fragments useful in the synthesis of analogs of halichondrin B | Jan 13, 2019 | Issued |
Array
(
[id] => 15853753
[patent_doc_number] => 10642155
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-05
[patent_title] => Mixed-type photosensitive resin and preparation method therefor
[patent_app_type] => utility
[patent_app_number] => 16/246379
[patent_app_country] => US
[patent_app_date] => 2019-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4555
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 242
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16246379
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/246379 | Mixed-type photosensitive resin and preparation method therefor | Jan 10, 2019 | Issued |
Array
(
[id] => 17756211
[patent_doc_number] => 11396495
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-26
[patent_title] => Amine compound for inhibiting SSAO/VAP-1 and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/770474
[patent_app_country] => US
[patent_app_date] => 2018-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44951
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16770474
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/770474 | Amine compound for inhibiting SSAO/VAP-1 and use thereof | Dec 27, 2018 | Issued |
Array
(
[id] => 17875489
[patent_doc_number] => 11447490
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-20
[patent_title] => Aromatic heterocyclic substituted olefin compound, preparation method for same, pharmaceutical composition of same, and applications thereof
[patent_app_type] => utility
[patent_app_number] => 16/964551
[patent_app_country] => US
[patent_app_date] => 2018-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20214
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1492
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16964551
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/964551 | Aromatic heterocyclic substituted olefin compound, preparation method for same, pharmaceutical composition of same, and applications thereof | Dec 27, 2018 | Issued |
Array
(
[id] => 16359381
[patent_doc_number] => 20200316132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => COMPOSITIONS AND METHODS FOR WILLIAMS SYNDROME (WS) THERAPY
[patent_app_type] => utility
[patent_app_number] => 16/955958
[patent_app_country] => US
[patent_app_date] => 2018-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40268
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16955958
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/955958 | Compositions and methods for Williams Syndrome (WS) therapy | Dec 20, 2018 | Issued |
Array
(
[id] => 15512631
[patent_doc_number] => 10562891
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-18
[patent_title] => Quinazolinones as PARP14 inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/227132
[patent_app_country] => US
[patent_app_date] => 2018-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 53363
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16227132
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/227132 | Quinazolinones as PARP14 inhibitors | Dec 19, 2018 | Issued |
Array
(
[id] => 16533271
[patent_doc_number] => 10875854
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-29
[patent_title] => Triazolopyridines
[patent_app_type] => utility
[patent_app_number] => 16/224507
[patent_app_country] => US
[patent_app_date] => 2018-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9657
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16224507
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/224507 | Triazolopyridines | Dec 17, 2018 | Issued |
Array
(
[id] => 14963025
[patent_doc_number] => 20190308990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => COMPOUNDS AND COMPOSITIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/214985
[patent_app_country] => US
[patent_app_date] => 2018-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30744
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16214985
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/214985 | Compounds and compositions and uses thereof | Dec 9, 2018 | Issued |
Array
(
[id] => 14158673
[patent_doc_number] => 20190106439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-11
[patent_title] => HETEROCYCLIC ITK INHIBITORS FOR TREATING INFLAMMATION AND CANCER
[patent_app_type] => utility
[patent_app_number] => 16/214573
[patent_app_country] => US
[patent_app_date] => 2018-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31115
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -55
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16214573
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/214573 | HETEROCYCLIC ITK INHIBITORS FOR TREATING INFLAMMATION AND CANCER | Dec 9, 2018 | Abandoned |
Array
(
[id] => 17029692
[patent_doc_number] => 11091497
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-17
[patent_title] => Pyrano[3,4-b]pyrazine kappa opioid receptor ligands for treating addiction, pruritus, pain, and inflammation
[patent_app_type] => utility
[patent_app_number] => 16/769858
[patent_app_country] => US
[patent_app_date] => 2018-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12669
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16769858
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/769858 | Pyrano[3,4-b]pyrazine kappa opioid receptor ligands for treating addiction, pruritus, pain, and inflammation | Dec 6, 2018 | Issued |
Array
(
[id] => 16169461
[patent_doc_number] => 10711009
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-14
[patent_title] => Method of preparing d-glucaro-1,4:6,3-dilactone
[patent_app_type] => utility
[patent_app_number] => 16/213461
[patent_app_country] => US
[patent_app_date] => 2018-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 3901
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 183
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16213461
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/213461 | Method of preparing d-glucaro-1,4:6,3-dilactone | Dec 6, 2018 | Issued |